Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Theoretical Biology
|
February 13, 2016
Honesty through repeated interactions
Patricia Rich, Kevin J S Zollman
Journal of Clinical Medicine
|
October 16, 2024
Malignant Pleural Mesothelioma: A Comprehensive Review
Molly Jain, Morgan Kay Crites, Patricia Rich, et al.
Topics in Cognitive Science
|
June 6, 2020
How Intractability Spans the Cognitive and Evolutionary Levels of Explanation
Patricia Rich, Mark Blokpoel, Ronald de Haan, et al.
Computational Brain & Behavior
|
December 26, 2024
Lessons for Theory from Scientific Domains Where Evidence is Sparse or Indirect
Marieke Woensdregt, Riccardo Fusaroli, Patricia Rich, et al.
Synthese
|
November 1, 2021
Naturalism, tractability and the adaptive toolbox
Patricia Rich, Mark Blokpoel, Ronald de Haan, et al.
Targeted Oncology
|
May 19, 2021
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
Benjamin Tan, Adnan Khattak, Enriqueta Felip, et al.
Targeted Oncology
|
October 17, 2020
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, et al.
Cancer
|
February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer
Luis Paz-Ares, David R Spigel, Yuanbin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2024
Reply to P. de Boissieu et al
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Theoretical Biology
|
February 13, 2016
Honesty through repeated interactions
Patricia Rich, Kevin J S Zollman
Journal of Clinical Medicine
|
October 16, 2024
Malignant Pleural Mesothelioma: A Comprehensive Review
Molly Jain, Morgan Kay Crites, Patricia Rich, et al.
Topics in Cognitive Science
|
June 6, 2020
How Intractability Spans the Cognitive and Evolutionary Levels of Explanation
Patricia Rich, Mark Blokpoel, Ronald de Haan, et al.
Computational Brain & Behavior
|
December 26, 2024
Lessons for Theory from Scientific Domains Where Evidence is Sparse or Indirect
Marieke Woensdregt, Riccardo Fusaroli, Patricia Rich, et al.
Synthese
|
November 1, 2021
Naturalism, tractability and the adaptive toolbox
Patricia Rich, Mark Blokpoel, Ronald de Haan, et al.
Targeted Oncology
|
May 19, 2021
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
Benjamin Tan, Adnan Khattak, Enriqueta Felip, et al.
Targeted Oncology
|
October 17, 2020
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, et al.
Cancer
|
February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer
Luis Paz-Ares, David R Spigel, Yuanbin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2024
Reply to P. de Boissieu et al
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Page
of 2